Why the study?
Does hypolipidemic therapy reduce common carotid artery intimal thickness in patients with familial hyperlipoproteinemias?
Does hypolipidemic therapy reduce common carotid artery intimal thickness in patients with familial hyperlipoproteinemias?
Answers are grounded in this paper and cite their sources.
Hypolipidemic therapy, particularly with statins, significantly decreases common carotid artery intimal thickness in patients with familial hyperlipoproteinemias, suggesting regression of early atherosclerosis.
It has been demonstrated in recent years that ultrasound can be used to measure common carotid artery intimal thickness; an increase in intimal thickness is regarded as an early stage of atherosclerosis. This study was designed to establish whether or not intimal thickness can be modulated by therapy. Twenty-nine patients with familial hyperlipoproteinemias had follow-up ultrasound of the common carotid artery after twenty-nine months of comprehensive therapy. In 21 patients with familial hypercholesterolemia, intimal thickness decreased from 0.83 to 0.68 mm (P < 0.01), in 9 with familial combined hyperlipoproteinemia, the decrease was from 0.77 to 0.74 mm (a decrease was seen in only 50% of patients). With the group taken as a whole, the larger decrease was observed in patients treated with statins while the reduction was less marked in those administered fibrates. The authors found a decrease in common carotid artery intimal thickness following hypolipidemic therapy in patients with hyperlipoproteinemias. Their impression is that this was a manifestation of atherosclerosis regression.
No takes yet. Share an insight, caveat, or question.
Spáčil et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: